替雷利珠单抗联合 Nab-PP 治疗 PD-L1 高表达晚期肺鳞癌的临床疗效
李萌, 张学琴, 赵晨阳, 邢源
The clinical efficacy of tislelizumab combined with Nab-PP in the treatment of advanced lung squamous cell carcinoma with high PD-L1 expression
LI Meng, ZHANG Xueqin, ZHAO Chenyang, XING Yuan
世界临床药物
.
2025, (12): 1290
.
DOI: 10.13683/j.wph. 2025.12.014
